7-ethyl-10-hydroxycamptothecin Completed Phase 1 Trials for Advanced Solid Tumors / Metastatic Triple Negative Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01238952Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer